Tokyo, June 26, 2006 (JCN) - Shin Nippon Biomedical Laboratories (SNBL) announced on June 26 that it has completed a joint research project with Takeda Pharmaceutical.
Since 2002, the two companies have collaborated in the search and analysis of organ-specific virulence-associated genes of cynomolgus ("crab-eating") monkeys. The aim of this collaboration is to develop an effective tool for analyzing and estimating the toxicity of drug candidates.
Through the four-year collaboration, the partners have analyzed genes expressed in the six main organs of cynomolgus monkeys and established a database that covers the entire genome sequences of cynomolgus monkey.
Further, they have created a customized DNA microarray that mounts representative sequences from 15,000 genes. Subsequently, they have confirmed that the customized DNA microarray can be used to evaluate toxicity in primates. Further, they have developed a gene expression database for 27 organs used in toxicity analysis.
Details of the joint research were presented at the 46th Annual Meeting of the Society of Toxicology and will be presented at the 33rd Annual Meeting of the Japanese Society of Toxicology, to be held in Nagoya in July.
Going forward, SNBL plans to proceed with research and aims to develop an innovative tool for toxicity analysis of drug candidates.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Companies Submit Joint Application Seeking Approval for Additional Indication for Helicobacter pylori
(Aug 31, 2012)
|
|
|
Takeda and Envoy Partner on Schizophrenia Research
(Oct 8, 2010)
|
|
|
Terumo, Takeda to Co-promote Takeda's Ethical Narcotic Formulations
(Sept 4, 2009)
|
|
|
XOMA, Takeda Expand Collaboration
(Feb 10, 2009)
|
|
|
Takeda Cuts FY '08 Earnings Forecasts on Stronger Yen
(Nov 5, 2008)
|
|
|
Takeda Ups Half-Year Earnings Estimates
(Oct 20, 2008)
|
|
|
Takeda Established a New Company for Asian Sales & Marketing
(Sept 25, 2008)
|
|
|
Takeda Established a New Company for Clinical Development in the Asia-Oceania Region
(Sept 25, 2008)
|
|
|
Shionogi to Acquire U.S. Drug Maker Sciele Pharma
(Sept 1, 2008)
|
|
|
Takeda Pharmaceutical Raises Earnings Forecast for FY 2008
(July 31, 2008)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Biotech news...
|
|
